How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Breast Cancer Imaging Market
- By Imaging Modality: Mammography, Ultrasound Imaging, Magnetic Resonance Imaging (MRI), Molecular Breast Imaging (MBI), Positron Emission Tomography (PET)
- By Technology: Digital Mammography, 3D Tomosynthesis, Contrast-Enhanced Mammography, Automated Breast Ultrasound (ABUS), Breast MRI with Contrast
- By End User: Hospitals, Diagnostic Imaging Centers, Breast Cancer Screening Clinics, Ambulatory Surgical Centers, Research Institutes
- By Application: Screening, Diagnostic Evaluation, Pre-surgical Planning, Treatment Monitoring, Recurrence Detection
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Mammography leads By Imaging Modality at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 284 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.170 →
- 11 Company Profiles 16 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Breast Cancer Imaging Market report
A complete, evidence-based study - 11 chapters and 119 sections covering market size, segmentation across 4 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Imaging Modality 5
Technology 5
End User 5
Application 5
Companies profiled
Hologic Inc.
GE Healthcare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems Corporation
Fujifilm Holdings Corporation
Carestream Health
Konica Minolta Inc.
Planmed Oy
Delphinus Medical Technologies Inc.
Dilon Technologies Inc.
Mammotome (Devicor Medical Products
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Hologic Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →GE Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Siemens Healthineers
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Canon Medical Systems Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Fujifilm Holdings Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Carestream Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Konica Minolta Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Planmed Oy
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Delphinus Medical Technologies Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Dilon Technologies Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Mammotome (Devicor Medical Products
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Inc.)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →SonoCine Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →SuperSonic Imagine
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Civco Medical Solutions
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,482M by 2033 · 9.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Mammography48.0
- Ultrasound Imaging6.9
- Magnetic Resonance Imaging (MRI)15.0
- Molecular Breast Imaging (MBI)14.7
- Positron Emission Tomography (PET)15.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,221M → $2,497M · 9.4%
Europe$851.2M → $1,770M · 9.6%
Asia Pacific$777.2M → $1,452M · 8.1%
Latin America$481.1M → $1,021M · 9.9%
Middle East and Africa$370.1M → $716.0M · 8.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.152026
9.162027
9.182028
9.192029
9.192030
9.212031
9.212032
9.242033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Hologic Inc.9.7
- GE Healthcare27.5
- Siemens Healthineers6.2
- Philips Healthcare8.7
- Canon Medical Systems Corporation6.2
- Fujifilm Holdings Corporation13.7
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Imaging Modality17.6%
Technology16.8%
End User19.1%
Application46.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.5
- Europe23.7
- Asia Pacific19.5
- Latin America13.7
- Middle East and Africa9.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Hologic Inc. | 83 | 79 | 76 | 98 | 74 | 74 | 81 |
| GE Healthcare | 73 | 92 | 91 | 86 | 80 | 79 | 84 |
| Siemens Healthineers | 71 | 66 | 63 | 64 | 75 | 71 | 68 |
| Philips Healthcare | 65 | 74 | 70 | 72 | 68 | 72 | 70 |
| Canon Medical Systems Corporation | 64 | 51 | 73 | 76 | 51 | 69 | 64 |
| Fujifilm Holdings Corporation | 63 | 61 | 61 | 51 | 47 | 71 | 59 |
| Carestream Health | 59 | 55 | 64 | 47 | 43 | 62 | 55 |
| Konica Minolta Inc. | 48 | 47 | 43 | 45 | 37 | 42 | 44 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Hologic Inc.
- GE Healthcare
- Siemens Healthineers
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Hologic Inc. | ◐ | ◐ | ◐ | ✓ | ✓ | − |
| GE Healthcare | ✓ | ✓ | ✓ | ◐ | ✓ | ◐ |
| Siemens Healthineers | ◐ | − | − | ◐ | ✓ | ◐ |
| Philips Healthcare | ◐ | ✓ | ◐ | − | ✓ | ✓ |
| Canon Medical Systems Corporation | ◐ | − | − | ✓ | − | ◐ |
| Fujifilm Holdings Corporation | ◐ | ◐ | ◐ | ◐ | − | ◐ |
| Carestream Health | − | − | − | ◐ | − | ◐ |
| Konica Minolta Inc. | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1GE Healthcare84
2Hologic Inc.81
3Philips Healthcare70
4Siemens Healthineers68
5Canon Medical Systems Corporation64
6Fujifilm Holdings Corporation59
7Carestream Health55
8Konica Minolta Inc.44
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Hologic Inc.GE Healthcare
Challenger2
Strong scale, closing on the leaders.
Siemens HealthineersPhilips Healthcare
Contender2
Focused players with pockets of strength.
Canon Medical Systems CorporationFujifilm Holdings Corporation
Niche2
Specialists in a single segment or region.
Carestream HealthKonica Minolta Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Imaging Modality in North America, then scale across Breast Cancer Imaging Market — a $424M beachhead inside a $6.79B market.
Beachhead (SOM)$424Mobtainable near-term
Serviceable (SAM)$2.60Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Mammography
Best fit — highest urgency & budget in Imaging Modality.
Economic buyer81 fit
Ultrasound Imaging
Strong fit — clear ROI and a fast path to value.
End user68 fit
Magnetic Resonance Imaging (MRI)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Imaging Modality in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Technology & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel26%
Digital / self-serve24%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Imaging Modality leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Breast Cancer Imaging Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified24%
Evaluation11%
Closed-won6%
$17.5KCAC
$105KLTV
6.0:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Breast Cancer Imaging Market is a high-growth opportunity — $5.48B by 2033, compounding at 10.8%.
TAM · 2025$2.42Btoday
TAM · 2033$5.48Bforecast
CAGR10.8%2027–2033
Cumulative$33.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.48BTotal addressable market
SAM$2.20BServiceable available market
SOM$463MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.8% CAGR
Demand compounds through 2033, outpacing GDP across Imaging Modality.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Imaging Modality moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.48BLarge & growingTAM by 2033 at 10.8% CAGR
$2.20BServiceable nowreachable with today’s model
$463MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.28BBear7.0% CAGR
$5.48BBase10.8% CAGR
$7.02BBull14.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Technology optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Breast Cancer Imaging Market — a $8.59B market by 2033. Plan: grow share from 7.9% to 16.7%.
Market size · 2033$8.59Btotal addressable
Market CAGR11.3%2027–2033
Target share16.7%from 7.9% today
Revenue ambition$1.43Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.9% | 16.7% | On track |
| Revenue | $626M | $1.43B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Behind |
| Gross margin | 38.0% | 44.4% | On track |
| Customer retention | 88.9% | 94.7% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Imaging Modality
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Technology capability
A defensible second engine — invest in Technology to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Imaging Modality share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Technology
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $147M capacity & capability investment
- Greenlight bolt-on M&A in Technology
- Authorise North America expansion plan
- Fund R&D program for Imaging Modality leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAt risk
- Input-cost & supply riskBehind
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Breast Cancer Imaging Market conversation — a $3.58B market you can size, segment and defend in minutes.
Market size · 2033$3.58Btotal opportunity
Growth3.2%CAGR to 2033
Addressable buyers1,513+accounts in scope
Typical ROI5.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Imaging Modality
Goal Grow share in Imaging Modality
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.5×return on cost, year one
< 3 mopayback period
$41K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Hologic Inc.GE HealthcareSiemens HealthineersPhilips HealthcareCanon Medical Systems CorporationFujifilm Holdings CorporationCarestream HealthKonica Minolta Inc.+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Breast Cancer Imaging Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Breast Cancer Imaging Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Orthopedic Extremity Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportSpinal Non Fusion Technologies Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportMechanical Thrombectomy Devices Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportVaginal Slings Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportVagus Nerve Stimulation(VNS) Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportVascular Guidewires Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportVasculitis Treatment Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportVein Illumination Device Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportVenous thromboembolism(VTE)Therapeutics Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportVenturi Masks Market
Market size, share, segmentation and regional forecast.
$450M market · 2025 base year
View reportVideo Laryngoscopes Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportVoice Prosthesis Devices Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.